Clinical Trials Browser

Phase 2 × Leiomyosarcoma × pazopanib × Clear all

Carcinosarcoma, Leiomyosarcoma, Recurrence

NCT01532687 2021-09-27

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

NCT01442662 2020-01-31

LMS03

Phase 2 Completed

106 enrolled

Sarcoma

Leiomyosarcoma, Neoplasm Metastasis

NCT00297258 2016-02-03

Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma

Phase 2 Completed

148 enrolled 8 charts

Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial

Clinical Trials

PazoDoble

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

LMS03

Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma